Stockhub

CStone Pharmaceuticals: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 September 2022

  • curprev 15:2915:29, 3 September 2022 95.149.241.133 talk 1,302 bytes +1,302 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-posi..."
Retrieved from "https://stockhub.co/research/CStone_Pharmaceuticals"